317 related articles for article (PubMed ID: 26537916)
1. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
[TBL] [Abstract][Full Text] [Related]
2. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
[TBL] [Abstract][Full Text] [Related]
4. IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1.
Palmer VL; Worth AN; Scott RL; Perry GA; Yan M; Li QZ; Swanson PC
Cell Immunol; 2018 Sep; 331():110-120. PubMed ID: 30017086
[TBL] [Abstract][Full Text] [Related]
5. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
7. Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.
Baglaenko Y; Manion KP; Chang NH; Loh C; Lajoie G; Wither JE
Genes Immun; 2015; 16(5):311-20. PubMed ID: 25973757
[TBL] [Abstract][Full Text] [Related]
8. CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky N; Gassner FJ; Asslaber D; Reinthaler P; Denk U; Flenady S; Hofbauer JP; Danner B; Rebhandl S; Harrer A; Geisberger R; Greil R; Egle A
Oncotarget; 2016 Aug; 7(31):49459-49469. PubMed ID: 27385215
[TBL] [Abstract][Full Text] [Related]
9. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.
Yanaba K; Bouaziz JD; Matsushita T; Tsubata T; Tedder TF
J Immunol; 2009 Jun; 182(12):7459-72. PubMed ID: 19494269
[TBL] [Abstract][Full Text] [Related]
10. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
Yang JQ; Wen X; Kim PJ; Singh RR
J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
[TBL] [Abstract][Full Text] [Related]
11. TLR4 supports the expansion of FasL
Wang K; Tao L; Su J; Zhang Y; Zou B; Wang Y; Zou M; Chen N; Lei L; Li X
Mol Immunol; 2017 Jul; 87():188-199. PubMed ID: 28505514
[TBL] [Abstract][Full Text] [Related]
12. IL-10 derived from CD1dhiCD5⁺ B cells regulates experimental autoimmune myasthenia gravis.
Sheng JR; Quan S; Soliven B
J Neuroimmunol; 2015 Dec; 289():130-8. PubMed ID: 26616882
[TBL] [Abstract][Full Text] [Related]
13. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
14. CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.
Sheng JR; Quan S; Soliven B
J Immunol; 2014 Sep; 193(6):2669-77. PubMed ID: 25135828
[TBL] [Abstract][Full Text] [Related]
15. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
[TBL] [Abstract][Full Text] [Related]
16. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
[TBL] [Abstract][Full Text] [Related]
18. Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.
Sillé FC; Martin C; Jayaraman P; Rothchild A; Besra GS; Behar SM; Boes M
Immunol Lett; 2011 Sep; 139(1-2):33-41. PubMed ID: 21565221
[TBL] [Abstract][Full Text] [Related]
19. Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.
Napolitano A; Pittoni P; Beaudoin L; Lehuen A; Voehringer D; MacDonald HR; Dellabona P; Casorati G
J Immunol; 2013 Apr; 190(7):3299-308. PubMed ID: 23427253
[TBL] [Abstract][Full Text] [Related]
20. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
